Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults | MicrobiomeTrials← Back to trialsNCT07363395
Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-01-06Est. Completion: 2026-10-01
Enrollment target: 72 participants Locations- Nucleus Network Minneapolis Clinic, Saint Paul, Minnesota, United States
Other microbiome trials you might be interested in
Lupus or SLESpondyloarthritis
Scurvy is an almost forgotten carential pathology, caused by a deep vitamin C (or ascorbic acid) deficiency, a priori ex…
Nice, FranceCompleted Dec 8, 2025
CHARCOT MARIE TOOTH DISEASE
The Charcot syndrome Marie Tooth is the most frequent hereditary neuromuscular diseases: there is no curative treatment …
Nice, FranceCompleted Aug 31, 2013
Recruiting
Chronic PainKnee Pain ChronicPost Operative Pain
Phase II Multicentre, pilot, parallel-group, blinded, 1:1 randomized controlled trial to determine the feasibility of co…
Toronto, CanadaEst. completion Dec 31, 2026